GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » YoY EPS Growth

Purple Biotech (XTAE:PPBT) YoY EPS Growth : 44.68% (As of Mar. 2024)


View and export this data going back to 1978. Start your Free Trial

What is Purple Biotech YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Purple Biotech's YoY EPS Growth for the quarter that ended in Mar. 2024 was 44.68%.

Purple Biotech's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ₪-0.05.

Purple Biotech YoY EPS Growth Historical Data

The historical data trend for Purple Biotech's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech YoY EPS Growth Chart

Purple Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.07 20.64 40.81 14.77 25.11

Purple Biotech Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.96 -25.33 14.85 45.97 44.68

Purple Biotech YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Purple Biotech's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(-0.337--0.45)/ | -0.45 |
=25.11 %

Purple Biotech's YoY EPS Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EPS Growth (Q: Mar. 2024 )
=(Earnings per Share (Diluted) (Q: Mar. 2024 )-Earnings per Share (Diluted) (Q: Mar. 2023 )) / | Earnings per Share (Diluted) (Q: Mar. 2023 )) |
=(-0.052--0.094)/ | -0.094 |
=44.68 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Purple Biotech YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Purple Biotech's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (XTAE:PPBT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » YoY EPS Growth
Comparable Companies
XTAE:GFC-M XTAE:EVGN XTAE:BONS XTAE:DNA XTAE:CBI XTAE:MTLF XTAE:CANF XTAE:BOLT XTAE:SLGN XTAE:KDST OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
PPBT:USA 1YI1:Germany
Address
4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104
Website
https://www.purple-biotech.com
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.